These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 2434069
1. Apolipoprotein B allotypes MB19(1) and MB19(2) in subjects with coronary artery disease and hypercholesterolemia. Young SG, Bertics SJ, Scott TM, Dubois BW, Beltz WF, Curtiss LK, Witztum JL. Arteriosclerosis; 1987; 7(1):61-5. PubMed ID: 2434069 [Abstract] [Full Text] [Related]
2. Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B. Young SG, Bertics SJ, Curtiss LK, Casal DC, Witztum JL. Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1101-5. PubMed ID: 2419898 [Abstract] [Full Text] [Related]
5. Isolation of allele-specific, receptor-binding-defective low density lipoproteins from familial defective apolipoprotein B-100 subjects. Arnold KS, Balestra ME, Krauss RM, Curtiss LK, Young SG, Innerarity TL. J Lipid Res; 1994 Aug; 35(8):1469-76. PubMed ID: 7989871 [Abstract] [Full Text] [Related]
6. Detection of human apolipoprotein B polymorphic species with one monoclonal antibody (BIP 45) against low density lipoprotein. Influence of this polymorphism on lipid levels and coronary artery stenosis. Duriez P, Vu Dac N, Koffigan M, Puchois P, Demarquilly C, Fievet C, Fievet P, Luyeye I, Bard JM, Fourrier JL. Atherosclerosis; 1987 Jul; 66(1-2):153-61. PubMed ID: 3632747 [Abstract] [Full Text] [Related]
7. Modification of the apolipoprotein B gene in HepG2 cells by gene targeting. Farese RV, Flynn LM, Young SG. J Clin Invest; 1992 Jul; 90(1):256-61. PubMed ID: 1321843 [Abstract] [Full Text] [Related]
8. Identification of apolipoprotein B100 polymorphisms that affect low-density lipoprotein metabolism: description of a new approach involving monoclonal antibodies and dynamic light scattering. Chatterton JE, Schlapfer P, Bütler E, Gutierrez MM, Puppione DL, Pullinger CR, Kane JP, Curtiss LK, Schumaker VN. Biochemistry; 1995 Jul 25; 34(29):9571-80. PubMed ID: 7626627 [Abstract] [Full Text] [Related]
9. Immunogenetic polymorphism of apolipoprotein B in humans: studies with a monoclonal anti-Ag(c) antibody. Tikkanen MJ. Am Heart J; 1987 Feb 25; 113(2 Pt 2):428-32. PubMed ID: 3544758 [Abstract] [Full Text] [Related]
13. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects. Rahmani M, Raiszadeh F, Allahverdian S, Kiaii S, Navab M, Azizi F. Atherosclerosis; 2002 Jun 07; 162(2):381-9. PubMed ID: 11996958 [Abstract] [Full Text] [Related]
14. The apolipoprotein B R3531C mutation. Characteristics of 24 subjects from 9 kindreds. Pullinger CR, Gaffney D, Gutierrez MM, Malloy MJ, Schumaker VN, Packard CJ, Kane JP. J Lipid Res; 1999 Feb 07; 40(2):318-27. PubMed ID: 9925662 [Abstract] [Full Text] [Related]
15. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. Nieminen MS, Mattila KJ, Aalto-Setälä K, Kuusi T, Kontula K, Kauppinen-Mäkelin R, Ehnholm C, Jauhiainen M, Valle M, Taskinen MR. Arterioscler Thromb; 1992 Jan 07; 12(1):58-69. PubMed ID: 1346250 [Abstract] [Full Text] [Related]